alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,076–3,100 of 27,380 studies, newest first · page 124 of 1096.

September 2025 25

  1. 2025-09-30

    Trends in Assisted Living and Memory Care Supply From 2019 to 2023

    ✓ Peer-reviewed Risk factors Journal of the American Medical Directors Association

    Key finding: Counties with a decrease or no change in AL supply compared with increase in AL supply had a larger proportion of the population aged 65+ years, lower median household income, and were more rural. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2025-09-30

    Cardiovascular Risk Trajectories and Risk of Developing Stroke and Dementia

    ✓ Peer-reviewed Vascular contributions Neurology

    Key finding: Among 2,335 participants (mean age 52.3 ± 11.2 years; 56.6% women), CVD risk trajectories over 10 years were classified as accelerated increase (29.2%), moderate increase (30.9%), or stable (39.9%). +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2025-09-30

    Role of nurses in supporting advance care planning for people living with dementia

    ✓ Peer-reviewed End-of-life care Nursing Older People

    Key finding: Advance care planning (ACP) is of particular relevance to people living with dementia due to the gradual loss of decision-making capacity and ability to communicate that they typically experience. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2025-09-30

    Designing and delivering palliative and end of life care research with people living with HIV: reflections from a co-produced study

    ✓ Peer-reviewed End-of-life care Research Involvement and Engagement

    Key finding: This has meant that fewer people are dying as a direct result of HIV, and the life expectancy for people living with HIV is almost the same as the general population in many countries. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2025-09-30

    Associations of adherence to a healthy sleep pattern with the dementia risk in the UK biobank

    ✓ Peer-reviewed Long-term cohort studies Alzheimer s Research & Therapy

    Key finding: During a median follow-up of 13.8 years, 3,035 incident dementia cases were recorded, including 1,304 Alzheimer's disease (AD) cases and 597 vascular dementia (VD) cases. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2025-09-30

    High Physical Fitness Is Associated With Better Cognitive Function in Older Adults With Dementia: A Cross-Sectional Study

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Aging and Physical Activity

    Key finding: A higher GPF was associated with better cognitive function in institutionalized older adults with dementia. +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2025-09-30

    Plasma p‐tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Plasma p-tau217 showed strong diagnostic performance for distinguishing AD from bvFTD (96% accuracy) and PPD (93% accuracy). +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2025-09-30

    Role of Artificial Intelligence in the Diagnosis of Dementia in the Elderly

    ✓ Peer-reviewed Getting a diagnosis International Journal of Community Pharmacy

    Key finding: Dementia, a progressive neurodegenerative disorder affecting memory, cognition, and behaviour, poses a major global health challenge in aging populations. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2025-09-30

    Structure-guided Docking of Benzene-1,3-Disulfonic Acid to the ApoE-HSPG Binding Site at Arginine 136 as a Christchurch-mimetic Therapeutic Strategy for Alzheimer Disease

    ✓ Peer-reviewed Genetics Clinical Neuropharmacology

    Key finding: Benzene-1,3-disulfonic acid exhibited strong binding to the Arg136-containing pocket with a top docking score of -5.93 kcal/mol and an estimated inhibition constant (Ki) of 44.6 µmol. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2025-09-30

    Social Disparities, Delirium Occurrence, and Related Outcomes Among Hospitalized Older Adults

    ✓ Peer-reviewed Risk factors Journal of the American Geriatrics Society

    Key finding: A total of 260,200 older adults were screened for delirium (median [IQR] age in years: 78.0 [74.0-84.0]; female: 143,402 [55.1%]; non-Hispanic Black: 40,737 [15.8%]; Hispanic: 30,760 [11.9%]; median [IQR] Area Deprivation Index: 4.0 [2.0-6.0]; median [IQR] Charlson Comorbidity Index: 10.0 [8.0-13.0]). +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2025-09-29

    Anti-Amyloid Therapies for Alzheimer’s Disease: Progress, Pitfalls, and the Path Ahead

    ✓ Peer-reviewed Treatments International Journal of Molecular Sciences

    Key finding: On the other hand, they also create significant safety risks, including amyloid-related imaging abnormalities (ARIA) and substantial operational requirements for health systems that are already under pressure.

    Full summary, score breakdown and related studies → Original source

  12. 2025-09-29

    Impaired Synaptic Plasticity Mechanisms in Alzheimer's Disease

    ✓ Peer-reviewed Disease mechanisms Metabolic brain disease

    Key finding: In particular, disruption of long-term potentiation (LTP) within the hippocampus, a region essential for learning and memory, plays a central role. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2025-09-29

    Obstructive Sleep Apnea and Aging: A Narrative Review

    ✓ Peer-reviewed Risk factors Sleep medicine research

    Key finding: It can greatly increase patient sleepiness, and is associated with cardiovascular and neurological disease. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2025-09-29

    Glucagon-like peptide-1 receptor agonists and mental health: a narrative review of emerging benefits and risks

    ✓ Peer-reviewed Drug development Journal of Yeungnam medical science

    Key finding: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes mellitus and obesity, are increasingly recognized for their significant impact on the central nervous system, leading to reports of both beneficial and adverse mental health effects. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2025-09-29

    Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study

    ✓ Peer-reviewed Biomarkers Acta neuropathologica

    Key finding: We also analyzed brain tissue from ten golden Syrian hamsters (Mesocricetus auratus) subjected to induced torpor (hibernation) versus euthermic (non-hibernating) states by quantifying multiple phosphorylated and non-phosphorylated tau peptides with an IP-MS method previously applied in human brain tissue. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2025-09-29

    Socioeconomic status modifies the association between adherence to the Mediterranean diet and cognitive outcomes: results from the Collaborative PROMED-COG Pooled Cohorts Study

    ✓ Peer-reviewed Prevention trials Social Psychiatry and Psychiatric Epidemiology

    Key finding: Cognitive decline occurred in 38.1% of participants but was not associated with MD adherence. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2025-09-29

    General practitioners’ practices and training needs in dementia care: a comparison of urban and rural areas in Kazakhstan

    ✓ Peer-reviewed Disparities Aging & Mental Health

    Key finding: Targeted interventions, as enhanced training and improved support systems, are essential to address these disparities and better support GPs. +1 more finding

    Full summary, score breakdown and related studies → Original source

  18. 2025-09-29

    Effects of a virtual iSupport Program on carers and people with dementia

    ✓ Peer-reviewed Caregiving Alzheimer s & Dementia

    Key finding: One hundred forty-nine carers enrolled in the study. +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2025-09-29

    Dependency Grammar Approach to the Syntactic Complexity in the Discourse of Alzheimer Patients

    ✓ Peer-reviewed Brain scans and imaging Behavioral Sciences

    Key finding: A total of 150 adults with AD and 150 healthy controls (HC) responded in English to interview prompts based on the Cookie Theft picture description task, and the results were compared. +2 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2025-09-29

    Dementia prevalence in the Wisconsin Longitudinal Study

    ✓ Peer-reviewed Getting a diagnosis Alzheimer s & Dementia

    Key finding: Cognitive status was determined for 5414 participants, with a dementia prevalence of 8.9% when assessed at a mean age of 81 years. +2 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2025-09-28

    Age-Associated Transcriptomic and Epigenetic Alterations in Mouse Hippocampus

    ✓ Peer-reviewed Genetics Aging cell

    Key finding: Aging represents a major risk for human neurodegenerative disorders, such as dementia and Alzheimer's disease, and is associated with a functional decline in neurons and impaired synaptic plasticity, leading to a gradual decline in memory. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2025-09-28

    Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program

    ✓ Peer-reviewed Prevention trials The Journals of Gerontology Series B

    Key finding: The project is expected to generate evidence on the effectiveness, feasibility, and cost-effectiveness of multidomain interventions implemented across diverse real-world settings, including community, hospital, and long-term care. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2025-09-28

    Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part B: Natural Compounds

    ✓ Peer-reviewed Disease mechanisms Pharmaceuticals

    Key finding: It suggests that Aβ aggregation is the initial trigger of neurotoxicity, setting off a cascade of pathological events including inflammation, oxidative stress, tau hyperphosphorylation, synaptic dysfunction, and, ultimately, dementia.

    Full summary, score breakdown and related studies → Original source

  24. 2025-09-28

    Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial

    ✓ Peer-reviewed Cognitive tests and assessment Drugs

    Key finding: A total of 325 participants enrolled and received study drug. +4 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2025-09-27

    XPro1595, a Selective Soluble TNF Neutralizer, in Early Alzheimer’s Disease with Inflammation (ADi): Results from the Phase 2 MINDFuL Trial

    ⚠ Preprint — not yet peer-reviewed Treatments medRxiv

    Key finding: The complete absence of ARIA distinguishes XPro1595 from amyloid-targeting therapies and supports its potential for use in combination strategies and potentially for those at a higher risk of ARIA. +4 more findings

    Scored 26 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →